Co-Authors
This is a "connection" page, showing publications co-authored by Karima Addetia and Jeremy Slivnick.
Connection Strength
3.914
-
Author Response to Unraveling the Impact of Perivascular Amyloid Deposition on Cardiac Remodeling in AL Amyloidosis. J Am Soc Echocardiogr. 2024 Dec; 37(12):1191-1192.
Score: 0.863
-
Perivascular Amyloid Deposition in Immunoglobulin Light Chain Cardiac Amyloidosis and Its Implications on Echocardiographic Cardiac Remodeling. J Am Soc Echocardiogr. 2024 10; 37(10):1010-1012.
Score: 0.853
-
Incremental prognostic value of cardiac magnetic resonance beyond biomarker staging in transthyretin cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2026 Sep 01; 27(9):1603-1612.
Score: 0.248
-
Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection. Circ Cardiovasc Imaging. 2026 Jun; 19(6):e019610.
Score: 0.243
-
Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool. Eur Heart J. 2025 10 22; 46(40):4090-4101.
Score: 0.234
-
Echocardiographic Detection of Regional Wall Motion Abnormalities Using Artificial Intelligence Compared to Human Readers. J Am Soc Echocardiogr. 2024 07; 37(7):655-663.
Score: 0.210
-
Preservation of Circumferential and Radial Left Ventricular Function as a Mitigating Mechanism for Impaired Longitudinal Strain in Early Cardiac Amyloidosis. J Am Soc Echocardiogr. 2023 12; 36(12):1290-1301.
Score: 0.202
-
Cardiovascular computed tomography for the detection of quadricuspid aortic valve: A case report. Radiol Case Rep. 2023 Oct; 18(10):3544-3548.
Score: 0.200
-
Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains. Eur Heart J Cardiovasc Imaging. 2023 05 31; 24(6):829-837.
Score: 0.198
-
Vascular Amyloid Deposition Is Highly Prevalent in Immunoglobulin Light Chain Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2023 08; 16(8):1121-1123.
Score: 0.196
-
Decoding right ventricular geometry: novel 3D echocardiography-derived global shape analysis across health and disease states. Eur Heart J Cardiovasc Imaging. 2026 02 27; 27(3):425-436.
Score: 0.060
-
Noninvasive assessment of left ventricular performance using pressure-volume loops, blood propulsion and strain tensors: results from the World Alliance of Societies of Echocardiography study. Eur Heart J Cardiovasc Imaging. 2025 08 29; 26(9):1518-1533.
Score: 0.058
-
Clinical and Echocardiographic Features of Individuals With Cardiac Amyloidosis at Risk for Future Thrombus Formation. J Am Soc Echocardiogr. 2025 Feb; 38(2):135-137.
Score: 0.055
-
Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024 05 31; 25(6):754-761.
Score: 0.053
-
Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival. Curr Probl Cardiol. 2024 Apr; 49(4):102417.
Score: 0.052
-
Normative values of the aortic valve area and Doppler measurements using two-dimensional transthoracic echocardiography: results from the Multicentre World Alliance of Societies of Echocardiography Study. Eur Heart J Cardiovasc Imaging. 2023 03 21; 24(4):415-423.
Score: 0.049
-
Artificial intelligence based left ventricular ejection fraction and global longitudinal strain in cardiac amyloidosis. Echocardiography. 2023 03; 40(3):188-195.
Score: 0.048
-
Multichamber Strain Predicts Atrial Fibrillation in Cardiac Amyloidosis. J Am Soc Echocardiogr. 2023 02; 36(2):257-259.
Score: 0.047
-
Prevalence of Right Atrial Impairment and Association with Outcomes in Cardiac Amyloidosis. J Am Soc Echocardiogr. 2022 08; 35(8):829-835.e1.
Score: 0.046